The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study
Obesity · 2026-08 · 34 (8) · 1623-1634
DOI: 10.1002/oby.70252 ↗At a glance
Journal article in Obesity, published online on 2026-07-08. Written by Yihua Guo and 7 co-authors. Institution: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Major MEDLINE topics: Thrombospondins, Adipose Tissue, Lipids. 50 references. The full text is freely available in PubMed Central. Funded by: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Lingang laboratory.
Abstract (original language)
Objective
This study examined sex‐stratified effects of R‐spondin 3 (RSPO3) expression levels on body fat and blood lipids and their potential mediation effects through sex hormones.
Methods
We performed a sex‐stratified genome‐wide association study (GWAS) of RSPO3 protein ( N = 18,529 men and 21,323 women). We used two‐sample Mendelian randomization (MR) to examine associations of RSPO3 expression with the outcomes. Sex‐stratified MR estimates were compared using the pairwise z score test and Cochran's Q test. We conducted two‐step MR analyses to explore mediation effects through sex hormones.
Results
Sex‐stratified GWAS identified nine loci associated with RSPO3 protein levels, including three novel signals and four female‐stratified loci. In women, RSPO3 protein levels were associated with visceral adipose tissue (β = 0.22, 95% CI = 0.10 to 0.34), waist circumference (0.10, 0.05 to 0.15), hip circumference (0.10, 0.05 to 0.15), triglycerides (0.22, 0.18 to 0.26), high‐density lipoprotein cholesterol (−0.17, −0.21 to −0.13), and apolipoprotein A (−0.11, −0.15 to −0.06). We also observed sex differences in these associations. Two‐step MR showed that RSPO3 protein levels affected six outcomes via sex hormone‐binding globulin in women, with little evidence in men.
Conclusions
Our findings indicated that RSPO3 could be a drug target for regulating body fat distribution and blood lipids in women.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission, Shanghai Key Laboratory for Endocrine Tumor, Shanghai Digita…
- MRC Integrative Epidemiology Unit at University of Bristol, Bristol, UK.
ORCID profiles: Jiqiu Wang
Funding
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Lingang laboratory
- National Natural Science Foundation of China
Cite
APA
Guo, Y., Chen, Z., Huang, L., Zhang, Z., Gong, Y., Yang, Q., Wang, J., & Zheng, J. (2026). The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study. Obesity, 34(8), 1623-1634. https://doi.org/10.1002/oby.70252
Vancouver
Guo Y, Chen Z, Huang L, Zhang Z, Gong Y, Yang Q, et al. The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study. Obesity. 2026;34(8):1623-1634. doi:10.1002/oby.70252
BibTeX
@article{Guo2026,
author = {Guo, Yihua and Chen, Zhihe and Huang, Lanhui and Zhang, Zhongyun and Gong, Yujia and Yang, Qian and Wang, Jiqiu and Zheng, Jie},
title = {The Sex‐Stratified Effects of RSPO3 Expression on Body Fat and Blood Lipids: An Omics Mendelian Randomization Study},
journal = {Obesity},
year = {2026},
volume = {34},
number = {8},
pages = {1623--1634},
doi = {10.1002/oby.70252}
}
EUVIMED